GPX4 and neoplasm: To inform our choice of ICI for testing the effect of GPX4 knockdown plus ICI treatment on TNBC progression in vivo, we used aggregated published human data of tumor GPX4 expression, ICI treatment, and overall survival from female patients in the online resource KMPlotter [34].